19 June 2013
Keywords: Shire, USA, Replagal, Velaglucerase, Fabry disease, Gaucher disease, BLA filing
Article | 23 December 2009
Specialty biopharmaceutical company Shire says that it has submitted a Biologics License Application (BLA) with the USA’s Food and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.